Positive proof of concept for arthritis treatment

Israel’s Raphael announced positive proof-of-concept clinical study results of its HPC1 non-psychoactive cannabinoid-based formula developed for the treatment of rheumatoid arthritis. 12 adult participants reported lower pain levels and better sleep quality.

https://finance.yahoo.com/news/raphael-pharmaceutical-announces-positive-proof-130000207.html

https://www.raphaelpharmaceutical.com/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *